Intellia Therapeutics, Inc. - Common Stock (NQ:NTLA)

12.19 +0.12 (+1.04%)

Streaming Delayed Price Updated: 10:36 AM EDT, Oct 1, 2026 Add to My Watchlist

Price and Volume

Volume	1,124,711
Open	11.98
Bid (Size)	12.16 (600)
Ask (Size)	12.19 (800)
Prev. Close	12.06
Today's Range	11.82 - 12.36
52wk Range	7.950 - 28.25
Shares Outstanding	88,140,978
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Could This Cathie Wood Stock Soar in 2027? ↗

September 27, 2026

This biotech has grabbed plenty of headlines recently.

Via The Motley Fool

Intellia Eyes Lonvo-z Launch as HAE PDUFA Nears, TTR Study Advances ↗

September 19, 2026

Intellia Therapeutics (NASDAQ:NTLA) executives outlined plans for a potential launch of its hereditary angioedema treatment, lonvo-z, while discussing the company’s ongoing Phase III program in...

Via MarketBeat

Performance

YTD	+32.3%	+32.3%
1 Month	-4.3%	-4.3%
3 Month	-29.3%	-29.3%
6 Month	-8.2%	-8.2%
1 Year	-29.4%	-29.4%

More News

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗

August 31, 2026

Via The Motley Fool

Intellia Therapeutics (NASDAQ:NTLA) Slips on Q2 Revenue Miss Despite In-Line Loss ↗

August 06, 2026

Via Chartmill

Intellia Therapeutics Inc (NASDAQ:NTLA) Reports Strong Q4 2025 Revenue Beat and Confirms Key 2026 Pipeline Milestones ↗

February 26, 2026

Via Chartmill

Intellia (NTLA) Q2 2026 Earnings Call Transcript ↗

August 13, 2026

Via The Motley Fool

Intellia Therapeutics Q2 Earnings Call Highlights ↗

August 07, 2026

Via MarketBeat

A New CRISPR "DNA Shredder" Could Change Gene-Editing -- What It Means for CRISPR Therapeutics ↗

July 08, 2026

Via The Motley Fool

Wall Street Thinks This High-Flying Biotech Stock Can Soar Another 57% ↗

July 01, 2026

Via The Motley Fool

Wall Street Expects This Growth Stock That's Already Climbed 70% to Almost Double -- And Here's Why. ↗

June 24, 2026

Via The Motley Fool

Intellia Therapeutics vs. Omeros: Which Emerging Biotech Stock Is a Better Buy in 2026? ↗

June 20, 2026

Via The Motley Fool

This Stock Is Up 58% This Year. Is It too Late to Buy? ↗

June 17, 2026

Via The Motley Fool

1 Sector Warren Buffett and Greg Abel Are Largely Ignoring -- and Why Investors Shouldn't ↗

June 03, 2026

Via The Motley Fool

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗

May 06, 2026

Via The Motley Fool

3 Biotech Stocks That Could Benefit from the Patent Cliff ↗

April 27, 2026

Via MarketBeat

Top movers in Friday's after hours session ↗

April 24, 2026

Via Chartmill

2 Healthcare Stocks to Buy and 1 to Approach With Caution ↗

April 15, 2026

Via The Motley Fool

This Cathie Wood Stock Is Up 47% This Year: Is It Too Late to Buy? ↗

March 08, 2026

Via The Motley Fool

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗

March 03, 2026

Via The Motley Fool

Investors Eye Explosive Growth in Anti-Aging Therapies as Market Targets $420B Milestone

March 03, 2026

Via FinancialNewsMedia

Why Did NTLA Stock Jump 10% In Pre-Market Today? ↗

March 02, 2026

Via Stocktwits

Intellia (NTLA) Q4 2025 Earnings Call Transcript ↗

February 26, 2026

Via The Motley Fool

This Cathie Wood Stock Is Already Up 41% This Year, But Is It a Buy? ↗

February 07, 2026

Via The Motley Fool

NTLA Stock Jumped 13% Today – What Is The Latest FDA Action All About? ↗

January 27, 2026

Via Stocktwits

Nasdaq, S&P 500 Futures Edge Higher Ahead Of Long Weekend: Why NVDA, MU, NTLA, ASTS Are On Traders' Radar Today ↗

January 16, 2026

Via Stocktwits

Frequently Asked Questions

Is Intellia Therapeutics, Inc. - Common Stock publicly traded?

Yes, Intellia Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Intellia Therapeutics, Inc. - Common Stock trade on?

Intellia Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Intellia Therapeutics, Inc. - Common Stock?

The ticker symbol for Intellia Therapeutics, Inc. - Common Stock is NTLA on the Nasdaq Stock Market

What is the current price of Intellia Therapeutics, Inc. - Common Stock?

The current price of Intellia Therapeutics, Inc. - Common Stock is 12.19

When was Intellia Therapeutics, Inc. - Common Stock last traded?

The last trade of Intellia Therapeutics, Inc. - Common Stock was at 10/01/26 10:36 AM ET

What is the market capitalization of Intellia Therapeutics, Inc. - Common Stock?

The market capitalization of Intellia Therapeutics, Inc. - Common Stock is 1.07B

How many shares of Intellia Therapeutics, Inc. - Common Stock are outstanding?

Intellia Therapeutics, Inc. - Common Stock has 1B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.